Leading research peptide manufacturer, Cambridge Research Biochemicals (CRB) announced today that it has signed a non-exclusive license with LI-COR Biosciences (LI-COR) to develop, manufacture and sell IRDye® and IRDye® QC-1 near-infrared dye-labelled peptides for research use only.
Posts By: CRB
RCUK Shared Services Centre Ltd extends contract with Cambridge Research Biochemicals
Leading research peptide manufacturer, Cambridge Research Biochemicals (CRB) announced today that it has extended its contract with RCUK Shared Services Centre Ltd (RCUK SSC Ltd) to supply custom synthesised peptides and custom generated polyclonal and monoclonal antibodies for a further 12 months.
Cambridge Research Biochemicals Signs Exclusive Japanese Distribution Deal with BioBridge
Leading research peptide manufacturer, Cambridge Research Biochemicals (CRB) announced today that it will be expanding its business into Asia through the signing of an exclusive deal with BioBridge.
Cambridge Research Biochemicals signs agreement with Life Technologies to offer custom dye labelled antibodies
Cambridge Research Biochemicals, the specialist peptide and custom antibody manufacturer based in the North East of England, has announced a significant expansion to its dye labelling offering.
Quotient Bioresearch signs strategic alliance with Cambridge Research Biochemicals
Quotient Bioresearch, a leading provider of early stage and specialist drug development services to pharmaceutical, biotechnology and medical device clients worldwide, has signed a strategic partnership agreement with Cambridge Research Biochemicals to provide a joint consultancy solution for tritium peptide labelling, offering significant cost and time savings to customers.
Cambridge Research Biochemicals expands peptide manufacturing capacity
Leading research peptide and antibody manufacturer, Cambridge Research Biochemicals (CRB), announced today that it has made a substantial investment in its peptide manufacturing capacity by buying the first Overture™ Robotic Peptide Library Synthesizer to be installed in Europe.
CRB and Durham University launch medical research project
North-East specialist peptide manufacturer Cambridge Research Biochemicals (CRB) has teamed up with Durham University to carry out important health research.
Double first for Cambridge Research Biochemicals
Leading research peptide and antibody manufacturer, Cambridge Research Biochemicals (CRB), announced today that it has triumphed in the ‘Outstanding Growth’ category of the Business for Life Awards hosted by The Centre of Excellence for Life Sciences (CELS) in Newcastle, UK.